# Wearable Device-Assisted Remote Management to Improve Prognosis in Patients With Acute Heart Failure Complicated by Atrial Fibrillation: WARM-HF Trial (Stage 2)

> **NCT07687862** · NA · NOT_YET_RECRUITING · sponsor: **Beijing Anzhen Hospital** · enrollment: 818 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Heart Failure and Reduced Ejection Fraction

## Interventions

- **DRUG:** wearable device based remote management (GDMT titration for HF, rhythm control and anticoagulation management for AF)

## Key facts

- **NCT ID:** NCT07687862
- **Lead sponsor:** Beijing Anzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-30
- **Target enrollment:** 818 (ESTIMATED)
- **Last updated:** 2026-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687862, "Wearable Device-Assisted Remote Management to Improve Prognosis in Patients With Acute Heart Failure Complicated by Atrial Fibrillation: WARM-HF Trial (Stage 2)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07687862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*